IP Library Granted Patent US 8,940,003
Granted Patent B2
US 8,940,003 · App. 12/918,795 · Granted Jan 27, 2015

Methods and apparatus for flow restoration

Inventors: Earl Howard Slee (Laguna Niguel, CA); Thomas Wilder, III (Newport Beach, CA); Thomas McCarthy (San Clemente, CA); David Franco (Irvine, CA); Mark Philip Ashby (Laguna Niguel, CA); Sanjay Shrivastava (Irvine, CA)
Assignee: Covidien LP
A61B17/22A61B17/221A61B2017/22034A61B2017/2215A61F2/90A61F2/91A61F2/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,940,003
App. No.
12/918,795
Granted
Jan 27, 2015
Kind
B2
Abstract

Methods for restoring blood flow in occluded blood vessels using an apparatus having a self expandable distal segment that is pre-formed to assume a superimposed structure in an unconstrained condition but can be made to take on a volume-reduced form making it possible to introduce it with a microcatheter and a push wire arranged at the proximal end, with the distal segment in its superimposed structure assuming the form of a longitudinally open tube and having a mesh structure of interconnected strings or filaments or struts. In a preferred embodiment, the distal segment has a tapering structure at its proximal end where the strings or filaments or struts converge at a connection point.

Claims (11)

1. A self-expandable apparatus for removal of a thrombus in a blood vessel, comprising:

a tubular structure having a proximal end and a distal end, the structure having (a) a distal portion comprising a first plurality of cells, (b) a proximal portion comprising a second plurality of cells,(c) a first diameter at the distal end, and (d) a second diameter at the proximal end, the distal portion having a distally widening taper at a distal end portion of the distal portion such that the first diameter is greater than the second diameter, the apparatus further comprising a connection point located at a proximal end of the proximal portion wherein the proximal portion converges at the connection point, the apparatus further comprising two edges extending parallel to a longitudinal axis of the structure, wherein the structure is configured to assume an expanded configuration at the place of implantation, and wherein the structure is configured to be modified into a volume-reduced configuration for insertion within a microcatheter, the volume-reduced configuration having a smaller cross-sectional dimension than the expanded configuration, the two edges being overlapped in the volume-reduced configuration, wherein the structure is configured to expand into the thrombus when transitioning from the volume-reduced configuration to the expanded configuration.

2. The apparatus of claim 1 , wherein the distal end of the structure comprises radiopaque markers having a spiral or eyelet shape.

3. The apparatus of claim 1 , wherein the distal end of the structure is bent and extends distally at an acute angle relative to the longitudinal axis of the structure.

4. The apparatus of claim 1 , the structure comprising a first plurality of cells at a proximal portion, a second plurality of cells at a tapered portion, and wherein the distal end of the structure comprises a third plurality of cells and wherein said third plurality of cells has a smaller cell size than the second plurality of cells.

5. The apparatus of claim 1 , wherein the distal end of the structure comprises one or more pegs and/or hooks.

6. The apparatus of claim 1 , wherein the distal end of the structure further comprises the addition of synthetic fibers.

7. The apparatus of claim 1 , wherein the distal end of the structure has been heated for a sufficient time to provide increased radial strength.

8. The apparatus of claim 1 , wherein the structure is coated with an anticoagulant or antiplatelet drug.

9. The apparatus of claim 8 , wherein the structure is further coated with a biodegradable, biocompatible polymer to provide for sustained release of the anticoagulant or antiplatelet drug.

10. The apparatus of claim 1 , wherein the structure comprises reservoirs to hold an anticoagulant or antiplatelet drug.

Assignments (5)
MERGER Recorded Dec 20, 2012
From: MICRO THERAPEUTICS, INC.
To: EV3 INC.
Reel/Frame 029512/0883 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 20, 2012
From: EV3 LLC
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 029513/0114 →
CHANGE OF NAME Recorded Dec 20, 2012
From: EV3 INC.
To: EV3 LLC
Reel/Frame 029530/0739 →
CHANGE OF NAME Recorded Dec 20, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029530/0764 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 22, 2010
From: SLEE, EARL HOWARD; WILDER, THOMAS, III; MCCARTHY, THOMAS; FRANCO, DAVID; ASHBY, MARK PHILIP; SHRIVASTAVA, SANJAY
To: MICRO THERAPEUTICS, INC.
Reel/Frame 025394/0295 →
Continuity (2)
Provisional Application 61030838 · Feb 22, 2008
Related Publication 20110060212A1 · Mar 10, 2011